Phio Pharmaceuticals Corp. risks delisting from Nasdaq after failing to meet minimum stock price requirements, with a compliance deadline set for May 2027.
| Name | Phio Pharmaceuticals Corp. |
|---|---|
| CIK | 0001533040 |
| Tickers | PHIO |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 453215903 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (508) 767-3861 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Phio Pharmaceuticals Corp. risks delisting from Nasdaq after failing to meet minimum stock price requirements, with a compliance deadline set for May 2027.
Phio Pharmaceuticals' CEO Robert J. Bitterman buys 25,000 shares, signaling confidence in the company's future in the pharmaceutical sector.
Phio Pharmaceuticals Corp. releases Q3 2026 results, highlighting progress in R&D and financial performance in the pharmaceutical preparations sector.
Phio Pharmaceuticals announces Q3 2026 financial results, highlighting key advancements in its PH-762 program and ongoing efforts in cancer treatment.
900 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | 8-K | FORM 8-K | 3.01 | 0001437749-26-037895 | 001-36304 | 261579301 | 34 | 158408 | 1 | 1 |
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001649553-26-000139 | 005-86901 | 261558783 | 34 | 12017 | |||
| 2026-11-16 | 4 | xslF345X06/ownership.xml | 0001683168-26-008786 | 6577 | ||||||
| 2026-11-12 | 4 | xslF345X06/ownership.xml | 0001683168-26-008544 | 7651 | ||||||
| 2026-11-10 | 4 | xslF345X06/ownership.xml | 0001683168-26-008471 | 4990 | ||||||
| 2026-11-10 | 4 | xslF345X06/ownership.xml | 0001683168-26-008469 | 5089 | ||||||
| 2026-11-05 | 10-Q | FORM 10-Q | 0001437749-26-035280 | 001-36304 | 261527512 | 34 | 3895087 | 1 | 1 | |
| 2026-11-05 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-26-035277 | 001-36304 | 261527467 | 34 | 264563 | 1 | 1 |
| 2026-10-13 | 8-K | FORM 8-K | 8.01,9.01 | 0001437749-26-032505 | 001-36304 | 261454873 | 34 | 182263 | 1 | 1 |
| 2026-09-30 | 4 | xslF345X06/ownership.xml | 0001683168-26-007499 | 6527 | ||||||
| 2026-09-29 | 4 | xslF345X06/ownership.xml | 0001683168-26-007481 | 5208 | ||||||
| 2026-09-29 | 4 | xslF345X06/ownership.xml | 0001683168-26-007483 | 5289 | ||||||
| 2026-09-29 | 4 | xslF345X06/ownership.xml | 0001683168-26-007482 | 5189 | ||||||
| 2026-09-28 | S-8 | FORM S-8 | 0001437749-26-031367 | 333-299168 | 261417761 | 33 | 201401 | 1 | 1 | |
| 2026-09-28 | 8-K | FORM 8-K | 5.02,5.07,9.01 | 0001437749-26-031337 | 001-36304 | 261417186 | 34 | 196856 | 1 | 1 |
| 2026-09-25 | 4 | xslF345X06/ownership.xml | 0001683168-26-007432 | 5043 | ||||||
| 2026-09-23 | 4 | xslF345X06/ownership.xml | 0001683168-26-007321 | 5090 | ||||||
| 2026-09-16 | 4 | xslF345X06/ownership.xml | 0001683168-26-007192 | 5042 | ||||||
| 2026-09-15 | 4 | xslF345X06/ownership.xml | 0001683168-26-007158 | 5290 | ||||||
| 2026-09-15 | 4 | xslF345X06/ownership.xml | 0001683168-26-007159 | 5372 | ||||||
| 2026-09-14 | 8-K | FORM 8-K | 8.01,9.01 | 0001437749-26-030236 | 001-36304 | 261375963 | 34 | 183558 | 1 | 1 |
| 2026-08-20 | 4 | xslF345X06/ownership.xml | 0001683168-26-006620 | 4800 | ||||||
| 2026-08-19 | 4 | xslF345X06/ownership.xml | 0001683168-26-006592 | 5089 | ||||||
| 2026-08-14 | ARS | ANNUAL REPORT | 0001683168-26-006475 | 001-36304 | 261281679 | 34 | 1233798 | |||
| 2026-08-14 | DEFA14A | ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS | 0001683168-26-006474 | 001-36304 | 261281639 | 34 | 1096357 | |||
| 2026-08-14 | DEF 14A | FORM DEF 14A | 0001437749-26-027997 | 001-36304 | 261281136 | 34 | 2062501 | 1 | 1 | |
| 2026-08-06 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-26-026275 | 001-36304 | 261249327 | 34 | 264421 | 1 | 1 |
| 2026-08-06 | 10-Q | FORM 10-Q | 0001437749-26-026271 | 001-36304 | 261249212 | 34 | 3751205 | 1 | 1 | |
| 2026-07-30 | 3 | xslF345X06/ownership.xml | 0001683168-26-005842 | 14833 | ||||||
| 2026-07-21 | 8-K | FORM 8-K | 5.02,8.01,9.01 | 0001437749-26-023916 | 001-36304 | 261188144 | 34 | 184984 | 1 | 1 |
| 2026-06-29 | 4 | xslF345X06/ownership.xml | 0001683168-26-005164 | 5089 | ||||||
| 2026-05-07 | 10-Q | FORM 10-Q | 0001437749-26-015604 | 001-36304 | 26953911 | 34 | 3498254 | 1 | 1 | |
| 2026-05-07 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-26-015590 | 001-36304 | 26953565 | 34 | 243978 | 1 | 1 |
| 2026-04-08 | 8-K | FORM 8-K | 1.01,9.01 | 0001437749-26-011761 | 001-36304 | 26848312 | 34 | 423402 | 1 | 1 |
| 2026-04-08 | 424B5 | PROSPECTUS SUPPLEMENT | 0001683168-26-002750 | 333-279557 | 26848263 | 33 | 389576 | |||
| 2026-03-30 | 8-K | FORM 8-K | 8.01 | 0001437749-26-010164 | 001-36304 | 26809958 | 34 | 175037 | 1 | 1 |
| 2026-03-05 | 10-K | FORM 10-K | 0001437749-26-007078 | 001-36304 | 26726374 | 34 | 6454256 | 1 | 1 | |
| 2026-03-05 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-26-007071 | 001-36304 | 26726193 | 34 | 234260 | 1 | 1 |
| 2026-02-18 | 8-K | FORM 8-K | 5.02 | 0001437749-26-004542 | 001-36304 | 26648066 | 34 | 172236 | 1 | 1 |
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001649553-26-000030 | 005-86901 | 26639917 | 34 | 11819 | |||
| 2026-02-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001213900-26-016522 | 005-86901 | 26634029 | 34 | 11627 | |||
| 2026-02-10 | 8-K | FORM 8-K | 8.01,9.01 | 0001437749-26-003575 | 001-36304 | 26613467 | 34 | 176290 | 1 | 1 |
| 2026-02-06 | 4 | xslF345X05/ownership.xml | 0001683168-26-000813 | 5247 | ||||||
| 2026-02-06 | 4 | xslF345X05/ownership.xml | 0001683168-26-000811 | 5243 | ||||||
| 2026-02-06 | 4 | xslF345X05/ownership.xml | 0001683168-26-000809 | 5097 | ||||||
| 2026-02-06 | 4 | xslF345X05/ownership.xml | 0001683168-26-000807 | 5068 | ||||||
| 2026-02-06 | 4 | xslF345X05/ownership.xml | 0001683168-26-000805 | 5273 | ||||||
| 2026-02-06 | 4 | xslF345X05/ownership.xml | 0001683168-26-000803 | 5151 | ||||||
| 2026-01-20 | 8-K | FORM 8-K | 8.01,9.01 | 0001437749-26-001500 | 001-36304 | 26541368 | 34 | 176024 | 1 | 1 |
| 2026-01-02 | 4 | xslF345X05/ownership.xml | 0001683168-26-000013 | 4950 | ||||||
| 2025-12-29 | 4 | xslF345X05/ownership.xml | 0001683168-25-009349 | 4951 | ||||||
| 2025-12-23 | 8-K | FORM 8-K | 8.01,9.01 | 0001437749-25-038607 | 001-36304 | 251595060 | 34 | 170850 | 1 | 1 |
| 2025-12-11 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001493152-25-027252 | 005-86901 | 251565383 | 34 | 7339 | |||
| 2025-12-04 | 424B3 | FORM 424B3 | 0001683168-25-008889 | 333-291667 | 251549362 | 33 | 140501 | |||
| 2025-12-03 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-003514 | 333-291667 | 251548162 | 33 | 1883 | ||
| 2025-12-01 | CORRESP | filename1.htm | 0001683168-25-008768 | 6956 | ||||||
| 2025-11-25 | 8-K | FORM 8-K | 8.01,9.01 | 0001437749-25-036329 | 001-36304 | 251521334 | 34 | 177185 | 1 | 1 |
| 2025-11-24 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001493152-25-024820 | 005-86901 | 251512924 | 34 | 7345 | |||
| 2025-11-24 | 4 | xslF345X05/ownership.xml | 0001683168-25-008639 | 4951 | ||||||
| 2025-11-20 | S-3 | REGISTRATION STATEMENT | 0001683168-25-008586 | 333-291667 | 251503091 | 33 | 594581 | 1 | 1 | |
| 2025-11-19 | 4 | xslF345X05/ownership.xml | 0001683168-25-008537 | 4951 | ||||||
| 2025-11-13 | 10-Q | FORM 10-Q | 0001437749-25-034857 | 001-36304 | 251478944 | 34 | 4756925 | 1 | 1 | |
| 2025-11-13 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-25-034848 | 001-36304 | 251478838 | 34 | 250367 | 1 | 1 |
| 2025-11-12 | D | xslFormDX01/primary_doc.xml | 06b | 0001123292-25-000633 | 021-563765 | 251473556 | 33 | 11608 | ||
| 2025-11-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001493152-25-021629 | 005-86901 | 251468321 | 34 | 7377 | |||
| 2025-11-10 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001649553-25-000206 | 005-86901 | 251467799 | 34 | 16193 | |||
| 2025-11-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001213900-25-107723 | 005-86901 | 251463725 | 34 | 13053 | |||
| 2025-11-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001493152-25-021091 | 005-86901 | 251459378 | 34 | 7306 | |||
| 2025-11-06 | 8-K | FORM 8-K | 1.01,3.02,8.01,9.01 | 0001437749-25-033600 | 001-36304 | 251458383 | 34 | 498539 | 1 | 1 |
| 2025-11-03 | 8-K | FORM 8-K | 8.01,9.01 | 0001437749-25-032662 | 001-36304 | 251442170 | 34 | 185067 | 1 | 1 |
| 2025-10-31 | 8-K | FORM 8-K | 5.02,8.01,9.01 | 0001437749-25-032512 | 001-36304 | 251438579 | 34 | 177754 | 1 | 1 |
| 2025-09-15 | 4/A | xslF345X05/ownership.xml | 0001683168-25-006986 | 5770 | ||||||
| 2025-09-15 | 8-K | FORM 8-K | 5.02,5.07 | 0001683168-25-006985 | 001-36304 | 251314299 | 34 | 216666 | 1 | 1 |
| 2025-09-15 | 4 | xslF345X05/ownership.xml | 0001683168-25-006961 | 17624 | ||||||
| 2025-09-15 | 4 | xslF345X05/ownership.xml | 0001683168-25-006959 | 17782 | ||||||
| 2025-09-15 | 4 | xslF345X05/ownership.xml | 0001683168-25-006958 | 17779 | ||||||
| 2025-09-15 | 4 | xslF345X05/ownership.xml | 0001683168-25-006957 | 17774 | ||||||
| 2025-09-15 | 4 | xslF345X05/ownership.xml | 0001683168-25-006956 | 5076 | ||||||
| 2025-09-15 | 4 | xslF345X05/ownership.xml | 0001683168-25-006955 | 17812 | ||||||
| 2025-09-15 | 4 | xslF345X05/ownership.xml | 0001683168-25-006954 | 19468 | ||||||
| 2025-09-11 | S-8 | REGISTRATION STATEMENT | 0001683168-25-006846 | 333-290186 | 251307423 | 33 | 338265 | 1 | 1 | |
| 2025-09-03 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001683168-25-006641 | 001-36304 | 251287790 | 34 | 215512 | 1 | 1 |
| 2025-08-28 | DEFA14A | ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS | 0001683168-25-006511 | 001-36304 | 251273202 | 34 | 16093 | |||
| 2025-08-27 | 424B3 | PROSPECTUS | 0001683168-25-006496 | 333-289621 | 251266313 | 33 | 131037 | |||
| 2025-08-22 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-002730 | 333-289621 | 251247809 | 33 | 1883 | ||
| 2025-08-21 | CORRESP | filename1.htm | 0001683168-25-006371 | 6458 | ||||||
| 2025-08-21 | UPLOAD | filename1.pdf | 0000000000-25-008902 | 333-289621 | 40239 | |||||
| 2025-08-15 | S-3 | REGISTRATION STATEMENT | 0001683168-25-006179 | 333-289621 | 251221595 | 33 | 606774 | 1 | 1 | |
| 2025-08-14 | 10-Q | FORM 10-Q FOR JUN 2025 | 0001683168-25-006174 | 001-36304 | 251220408 | 34 | 5198673 | 1 | 1 | |
| 2025-08-14 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001683168-25-006171 | 001-36304 | 251219672 | 34 | 248426 | 1 | 1 |
| 2025-08-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001641172-25-022581 | 005-86901 | 251193893 | 34 | 7400 | |||
| 2025-08-04 | D | xslFormDX01/primary_doc.xml | 06b | 0001123292-25-000336 | 021-553575 | 251178840 | 33 | 11300 | ||
| 2025-07-30 | 8-K | FORM 8-K | 1.01,3.02,8.01,9.01 | 0001683168-25-005523 | 001-36304 | 251166945 | 34 | 598462 | 1 | 1 |
| 2025-07-30 | ARS | FORM ARS | 0001683168-25-005522 | 001-36304 | 251166918 | 34 | 1434001 | |||
| 2025-07-30 | DEFA14A | ADDITIONAL DEFINITIVE PROXY MATERIALS | 0001683168-25-005521 | 001-36304 | 251166911 | 34 | 844134 | |||
| 2025-07-30 | DEF 14A | DEFINITIVE PROXY | 0001683168-25-005520 | 001-36304 | 251166895 | 34 | 1468980 | 1 | 1 | |
| 2025-07-25 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001683168-25-005392 | 001-36304 | 251150979 | 34 | 232763 | 1 | 1 |
| 2025-07-07 | 8-K | CURRENT REPORT | 8.01 | 0001683168-25-004948 | 001-36304 | 251107945 | 34 | 197606 | 1 | 1 |
| 2025-06-26 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001683168-25-004759 | 001-36304 | 251074855 | 34 | 217863 | 1 | 1 |
| 2025-06-18 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-011890 | 22798 | ||||||
| 2025-06-12 | 8-K | FORM 8-K | 5.02,9.01 | 0001683168-25-004421 | 001-36304 | 251041665 | 34 | 307404 | 1 | 1 |
| 2025-06-11 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-011424 | 4794 | ||||||
| 2025-06-11 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-011423 | 4673 | ||||||
| 2025-06-10 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-011326 | 4794 | ||||||
| 2025-05-23 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-010155 | 6430 | ||||||
| 2025-05-21 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-009985 | 5250 | ||||||
| 2025-05-15 | 10-Q | FORM 10-Q | 0001683168-25-003719 | 001-36304 | 25954321 | 34 | 3089549 | 1 | 1 | |
| 2025-05-15 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001683168-25-003715 | 001-36304 | 25954173 | 34 | 253291 | 1 | 1 |
| 2025-05-07 | 8-K | FORM 8-K | 8.01,9.01 | 0001683168-25-003237 | 001-36304 | 25921566 | 34 | 219952 | 1 | 1 |
| 2025-04-22 | 8-K | FORM 8-K | 4.01,9.01 | 0001683168-25-002725 | 001-36304 | 25857707 | 34 | 206260 | 1 | 1 |
| 2025-04-09 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001683168-25-002355 | 001-36304 | 25823885 | 34 | 222620 | 1 | 1 |
| 2025-03-31 | 10-K | FORM 10-K FOR DEC 2024 | 0001683168-25-002134 | 001-36304 | 25794120 | 34 | 6089095 | 1 | 1 | |
| 2025-03-31 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001683168-25-002131 | 001-36304 | 25793459 | 34 | 259082 | 1 | 1 |
| 2025-03-04 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-004347 | 11798 | ||||||
| 2025-02-20 | 8-K | FORM 8-K | 5.02,8.01,9.01 | 0001683168-25-001137 | 001-36304 | 25644859 | 34 | 221755 | 1 | 1 |
| 2025-02-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001649553-25-000039 | 005-86901 | 25601786 | 34 | 11869 | |||
| 2025-01-29 | 424B3 | PROSPECTUS | 0001683168-25-000577 | 333-284381 | 25569306 | 33 | 992813 | |||
| 2025-01-28 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000224 | 333-284381 | 25566448 | 33 | 1885 | ||
| 2025-01-28 | D | xslFormDX01/primary_doc.xml | 06b | 0001123292-25-000031 | 021-536530 | 25564397 | 33 | 11522 | ||
| 2025-01-28 | D | xslFormDX01/primary_doc.xml | 06b | 0001123292-25-000029 | 021-536528 | 25564276 | 33 | 11522 | ||
| 2025-01-28 | D | xslFormDX01/primary_doc.xml | 06b | 0001123292-25-000027 | 021-536524 | 25564176 | 33 | 11408 | ||
| 2025-01-27 | CORRESP | filename1.htm | 0001683168-25-000550 | 6921 | ||||||
| 2025-01-24 | UPLOAD | filename1.pdf | 0000000000-25-000806 | 333-284381 | 40272 | |||||
| 2025-01-23 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001493152-25-003376 | 005-86901 | 25549913 | 34 | 7453 | |||
| 2025-01-21 | S-1 | S-1 | 0001683168-25-000460 | 333-284381 | 25542998 | 33 | 4354086 | 1 | 1 | |
| 2025-01-17 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001213900-25-004657 | 005-86901 | 25539245 | 34 | 24777 | |||
| 2025-01-17 | 8-K | CURRENT REPORT | 1.01,3.02,8.01,9.01 | 0001683168-25-000426 | 001-36304 | 25538660 | 34 | 871249 | 1 | 1 |
| 2025-01-17 | 424B5 | FORM 424B5 | 0001683168-25-000413 | 333-279557 | 25537042 | 33 | 408313 | |||
| 2025-01-15 | 8-K | CURRENT REPORT | 1.01,3.02,8.01,9.01 | 0001683168-25-000384 | 001-36304 | 25532944 | 34 | 871362 | 1 | 1 |
| 2025-01-15 | 424B5 | PROSPECTUS | 0001683168-25-000356 | 333-279557 | 25531204 | 33 | 402328 | |||
| 2025-01-14 | 8-K | CURRENT REPORT | 1.01,8.01,9.01 | 0001683168-25-000347 | 001-36304 | 25530241 | 34 | 864577 | 1 | 1 |
| 2025-01-14 | 424B5 | PROSPECTUS | 0001683168-25-000324 | 333-279557 | 25528736 | 33 | 398093 | |||
| 2025-01-13 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001683168-25-000274 | 001-36304 | 25525322 | 34 | 221318 | 1 | 1 |
| 2025-01-07 | D | xslFormDX01/primary_doc.xml | 06b | 0001123292-25-000005 | 021-534479 | 25514937 | 33 | 11461 | ||
| 2025-01-03 | D | xslFormDX01/primary_doc.xml | 06b | 0001123292-25-000003 | 021-534199 | 25507033 | 33 | 11429 | ||
| 2024-12-27 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001213900-24-113155 | 005-86901 | 241586261 | 34 | 19306 | |||
| 2024-12-26 | 8-K | FORM 8-K | 1.01,3.02,8.01,9.01 | 0001683168-24-008984 | 001-36304 | 241581059 | 34 | 867907 | 1 | 1 |
| 2024-12-26 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-24-131663 | 005-86901 | 241580508 | 34 | 20037 | |||
| 2024-12-23 | 424B5 | FORM 424B5 | 0001683168-24-008939 | 333-279557 | 241573609 | 33 | 388587 | |||
| 2024-12-20 | 8-K | CURRENT REPORT | 1.01,3.02,8.01,9.01 | 0001683168-24-008884 | 001-36304 | 241567922 | 34 | 865735 | 1 | 1 |
| 2024-12-20 | 424B5 | PROSPECTUS SUPPLEMENT | 0001683168-24-008867 | 333-279557 | 241565160 | 33 | 383167 | |||
| 2024-12-19 | 8-K | FORM 8-K | 8.01,9.01 | 0001683168-24-008833 | 001-36304 | 241561069 | 34 | 219890 | 1 | 1 |
| 2024-11-14 | 10-Q | FORM 10-Q FOR SEPT 2024 | 0001683168-24-008120 | 001-36304 | 241463715 | 34 | 3460737 | 1 | 1 | |
| 2024-11-14 | 8-K | FORM 8-K | 2.02,9.01 | 0001683168-24-008118 | 001-36304 | 241463681 | 34 | 263315 | 1 | 1 |
| 2024-11-13 | SC 13G/A | AMENDMENT NO. 5 TO SCHEDULE 13G | 0001213900-24-097266 | 005-86901 | 241452128 | 34 | 53846 | |||
| 2024-11-07 | 8-K | FORM 8-K | 8.01,9.01 | 0001683168-24-007713 | 001-36304 | 241433727 | 34 | 227256 | 1 | 1 |
| 2024-09-13 | 4 | xslF345X05/ownership.xml | 0001683168-24-006377 | 5119 | ||||||
| 2024-09-13 | 4 | xslF345X05/ownership.xml | 0001683168-24-006375 | 5074 | ||||||
| 2024-09-13 | 4 | xslF345X05/ownership.xml | 0001683168-24-006373 | 5149 | ||||||
| 2024-09-12 | 4 | xslF345X05/ownership.xml | 0001683168-24-006336 | 5074 | ||||||
| 2024-09-12 | 4 | xslF345X05/ownership.xml | 0001683168-24-006334 | 5071 | ||||||
| 2024-09-12 | 4 | xslF345X05/ownership.xml | 0001683168-24-006332 | 5111 | ||||||
| 2024-08-15 | 4 | xslF345X05/ownership.xml | 0001683168-24-005773 | 5190 | ||||||
| 2024-08-14 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001683168-24-005707 | 001-36304 | 241209257 | 34 | 254509 | 1 | 1 |
| 2024-08-14 | 10-Q | FORM 10-Q FOR JUNE 2024 | 0001683168-24-005706 | 001-36304 | 241209002 | 34 | 3454763 | 1 | 1 | |
| 2024-08-09 | 3 | xslF345X02/ownership.xml | 0001683168-24-005394 | 3168 | ||||||
| 2024-08-05 | 424B3 | FORM 424B3 | 0001683168-24-005259 | 333-281052 | 241173141 | 33 | 176063 | |||
| 2024-08-01 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2024-08-01 16:00:00 | 9999999995-24-002365 | 333-281052 | 241168693 | 33 | 1886 | ||
| 2024-08-01 | 8-K | CURRENT REPORT | 5.02,9.01 | 0001683168-24-005194 | 001-36304 | 241164414 | 34 | 302929 | 1 | 1 |
| 2024-07-30 | CORRESP | filename1.htm | 0001683168-24-005128 | 7434 | ||||||
| 2024-07-29 | UPLOAD | filename1.pdf | 0000000000-24-008615 | 333-281052 | 40313 | |||||
| 2024-07-26 | S-1 | REGISTRATION STATEMENT | 0001683168-24-005092 | 333-281052 | 241147381 | 33 | 586470 | 1 | 1 | |
| 2024-07-24 | 8-K | FORM 8-K | 8.01 | 0001683168-24-005049 | 001-36304 | 241138445 | 34 | 198495 | 1 | 1 |
| 2024-07-24 | D | xslFormDX01/primary_doc.xml | 06b | 0001123292-24-000200 | 021-519563 | 241135646 | 33 | 10768 | ||
| 2024-07-12 | 8-K | FORM 8-K | 1.01,3.02,8.01,9.01 | 0001683168-24-004800 | 001-36304 | 241114839 | 34 | 593242 | 1 | 1 |
| 2024-07-05 | 8-K | FORM 8-K | 1.02,8.01,9.01 | 0001683168-24-004683 | 001-36304 | 241101687 | 34 | 211930 | 1 | 1 |
| 2024-07-02 | 8-K | FORM 8-K | 3.03,5.03,8.01,9.01 | 0001683168-24-004619 | 001-36304 | 241096677 | 34 | 245404 | 1 | 1 |
| 2024-07-01 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-07-01 16:00:00 | 9999999995-24-002034 | 333-279557 | 241092806 | 33 | 1886 | ||
| 2024-06-27 | CORRESP | filename1.htm | 0001683168-24-004524 | 6981 | ||||||
| 2024-06-21 | 8-K | FORM 8-K | 5.02,5.07,9.01 | 0001683168-24-004417 | 001-36304 | 241061092 | 34 | 397361 | 1 | 1 |
| 2024-06-11 | 4 | xslF345X05/ownership.xml | 0001683168-24-004126 | 4948 | ||||||
| 2024-06-10 | 4 | xslF345X05/ownership.xml | 0001683168-24-004089 | 4949 | ||||||
| 2024-05-28 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001683168-24-003849 | 001-36304 | 24992824 | 34 | 218076 | 1 | 1 |
| 2024-05-24 | UPLOAD | filename1.pdf | 0000000000-24-006053 | 333-279557 | 40460 | |||||
| 2024-05-20 | S-3 | FORM S-3 | 0001683168-24-003698 | 333-279557 | 24965533 | 33 | 692787 | 1 | 1 | |
| 2024-05-20 | RW | FORM RW | 0001683168-24-003696 | 333-279511 | 24965479 | NE | 8209 | |||
| 2024-05-17 | S-1 | S-3 | 0001683168-24-003624 | 333-279511 | 24960629 | 33 | 693548 | 1 | 1 | |
| 2024-05-17 | 424B5 | PROSPECTUS | 0001683168-24-003600 | 333-256100 | 24957874 | 33 | 370294 | |||
| 2024-05-17 | 8-K | FORM 8-K | 1.01,8.01,9.01 | 0001683168-24-003598 | 001-36304 | 24957855 | 34 | 449468 | 1 | 1 |
| 2024-05-09 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001683168-24-003178 | 001-36304 | 24931996 | 34 | 245514 | 1 | 1 |
| 2024-05-09 | 10-Q | FORM 10-Q FOR 3/31/24 | 0001683168-24-003175 | 001-36304 | 24931976 | 34 | 2772052 | 1 | 1 | |
| 2024-05-08 | DEFA14A | FORM DEFA14A | 0001683168-24-003114 | 001-36304 | 24927338 | 34 | 480503 | |||
| 2024-05-08 | DEF 14A | DEFINITIVE PROXY STATEMENT | 0001683168-24-003113 | 001-36304 | 24927300 | 34 | 2497273 | |||
| 2024-05-08 | ARS | ANNUAL REPORT TO SECURITY HOLDERS | 0001683168-24-003112 | 001-36304 | 24927271 | 34 | 1439146 | |||
| 2024-04-22 | PRE 14A | PRELIMINARY PROXY STATEMENT | 0001683168-24-002589 | 001-36304 | 24861930 | 34 | 916682 | |||
| 2024-04-02 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001683168-24-002050 | 001-36304 | 24812219 | 34 | 252185 | 1 | 1 |
| 2024-04-01 | 10-K | 10-K FOR 12/31/23 | 0001683168-24-002021 | 001-36304 | 24809882 | 34 | 5231271 | 1 | 1 | |
| 2024-03-05 | 4 | xslF345X05/ownership.xml | 0001683168-24-001324 | 5172 | ||||||
| 2024-02-27 | 4 | xslF345X05/ownership.xml | 0001683168-24-001216 | 4932 | ||||||
| 2024-02-22 | 4 | xslF345X05/ownership.xml | 0001683168-24-001134 | 5224 | ||||||
| 2024-02-20 | 4 | xslF345X05/ownership.xml | 0001683168-24-001086 | 6717 | ||||||
| 2024-02-06 | SC 13G/A | AMENDMENT NO. 4 TO SCHEDULE 13G | 0001213900-24-010340 | 005-86901 | 24598796 | 34 | 56133 | |||
| 2024-01-26 | 8-K | FORM 8-K | 3.01 | 0001683168-24-000489 | 001-36304 | 24568734 | 34 | 199342 | 1 | 1 |
| 2023-12-28 | 424B3 | 424B3 | 0001683168-23-009119 | 333-276146 | 231519670 | 33 | 156916 | |||
| 2023-12-27 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2023-12-27 16:00:00 | 9999999995-23-003764 | 333-276146 | 231519256 | 33 | 1874 | ||
| 2023-12-22 | CORRESP | filename1.htm | 0001683168-23-009065 | 6730 | ||||||
| 2023-12-21 | UPLOAD | filename1.pdf | 0000000000-23-013985 | 40405 | ||||||
| 2023-12-19 | S-1 | REGISTRATION STATEMENT | 0001683168-23-008964 | 333-276146 | 231498126 | 33 | 577921 | 1 | 1 | |
| 2023-12-19 | D | xslFormDX01/primary_doc.xml | 06b | 0001123292-23-000208 | 021-500104 | 231496472 | 33 | 10538 | ||
| 2023-12-08 | 8-K | CURRENT REPORT | 1.01,3.02,8.01,9.01 | 0001683168-23-008732 | 001-36304 | 231476209 | 34 | 573892 | 1 | 1 |
| 2023-11-09 | 8-K | CURRENT REPORT | 2.02,8.01,9.01 | 0001683168-23-007815 | 001-36304 | 231393281 | 34 | 262108 | 1 | 1 |
| 2023-11-09 | 10-Q | FORM 10-Q FOR SEPT 2023 | 0001683168-23-007809 | 001-36304 | 231393104 | 34 | 3259302 | 1 | 1 | |
| 2023-10-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-051706 | 5198 | ||||||
| 2023-09-29 | S-8 | FORM S-8 | 0001683168-23-006837 | 333-274787 | 231296168 | 33 | 84029 | |||
| 2023-08-21 | 8-K | FORM 8-K | 8.01,9.01 | 0001683168-23-005923 | 001-36304 | 231187331 | 34 | 221949 | 1 | 1 |
| 2023-08-10 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001683168-23-005515 | 001-36304 | 231160219 | 34 | 251160 | 1 | 1 |
| 2023-08-10 | 10-Q | QUARTERLY REPORT | 0001683168-23-005514 | 001-36304 | 231160051 | 34 | 2956814 | 1 | 1 | |
| 2023-07-26 | 8-K | FORM 8-K | 5.02,5.07,9.01 | 0001683168-23-005094 | 001-36304 | 231113991 | 34 | 394471 | 1 | 1 |
| 2023-07-05 | 4 | FORM 4 SUBMISSION | 0001209191-23-041254 | 6491 | ||||||
| 2023-06-20 | 424B3 | 424B3 | 0001683168-23-004247 | 333-272526 | 231023736 | 33 | 168143 | |||
| 2023-06-16 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2023-06-16 17:00:00 | 9999999995-23-001782 | 333-272526 | 231023187 | 33 | 1825 | ||
| 2023-06-15 | 4 | FORM 4 SUBMISSION | 0001209191-23-037408 | 4790 | ||||||
| 2023-06-14 | CORRESP | filename1.htm | 0001683168-23-004114 | 6379 | ||||||
| 2023-06-14 | UPLOAD | filename1.pdf | 0000000000-23-006396 | 40374 | ||||||
| 2023-06-13 | D | xslFormDX01/primary_doc.xml | 06b | 0001683168-23-004102 | 021-484103 | 231011740 | 33 | 11598 | ||
| 2023-06-09 | ARS | ANNUAL REPORT TO SECURITY HOLDERS | 0001683168-23-004047 | 001-36304 | 231005837 | 34 | 1649397 | |||
| 2023-06-09 | DEFA14A | PROXY CARD | 0001683168-23-004046 | 001-36304 | 231005817 | 34 | 456161 | |||
| 2023-06-09 | DEF 14A | DEFINITIVE PROXY STATEMENT | 0001683168-23-004045 | 001-36304 | 231005761 | 34 | 3610435 | |||
| 2023-06-08 | S-1 | REGISTRATION STATEMENT | 0001683168-23-004016 | 333-272526 | 231002749 | 33 | 582689 | 1 | 1 | |
| 2023-06-02 | 8-K | FORM 8-K | 1.01,3.02,8.01,9.01 | 0001683168-23-003863 | 001-36304 | 23989295 | 34 | 1463739 | 1 | 1 |
| 2023-06-01 | 424B5 | 424B5 | 0001683168-23-003815 | 333-256100 | 23985493 | 33 | 369152 | |||
| 2023-05-24 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001683168-23-003671 | 001-36304 | 23950608 | 34 | 221452 | 1 | 1 |
| 2023-05-16 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001683168-23-003433 | 001-36304 | 23925579 | 34 | 218302 | 1 | 1 |
| 2023-05-11 | 8-K | FORM 8-K | 2.02,9.01 | 0001683168-23-003214 | 001-36304 | 23912036 | 34 | 251313 | 1 | 1 |
| 2023-05-11 | 10-Q | FORM 10-Q | 0001683168-23-003213 | 001-36304 | 23912014 | 34 | 3021899 | 1 | 1 | |
| 2023-05-10 | 424B3 | PROSPECTUS | 0001683168-23-003127 | 333-271521 | 23906977 | 33 | 141178 | |||
| 2023-05-09 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2023-05-09 16:00:00 | 9999999995-23-001352 | 333-271521 | 23904117 | 33 | 1824 | ||
| 2023-05-05 | CORRESP | filename1.htm | 0001683168-23-002979 | 6786 | ||||||
| 2023-05-05 | UPLOAD | filename1.pdf | 0000000000-23-004688 | 40358 | ||||||
| 2023-05-02 | D | xslFormDX01/primary_doc.xml | 06b | 0001683168-23-002852 | 021-480606 | 23879197 | 33 | 11639 | ||
| 2023-04-28 | S-1 | S-1 | 0001683168-23-002765 | 333-271521 | 23868127 | 33 | 312308 | |||
| 2023-04-20 | 8-K | FORM 8-K | 8.01,9.01 | 0001683168-23-002559 | 001-36304 | 23834007 | 34 | 204162 | 1 | 1 |
| 2023-04-20 | 424B3 | PROSPECTUS SUPPLEMENT | 0001683168-23-002554 | 333-224799 | 23832785 | 33 | 13074 | |||
| 2023-04-20 | 424B3 | FORM 424(B)(3) | 0001683168-23-002552 | 333-252588 | 23832783 | 33 | 13050 | |||
| 2023-04-20 | 424B3 | 424(B)(3) | 0001683168-23-002550 | 333-234032 | 23832753 | 33 | 13250 | |||
| 2023-04-20 | 424B3 | FORM 424(B)(3) | 0001683168-23-002548 | 333-238204 | 23832746 | 33 | 13124 | |||
| 2023-04-20 | 424B3 | FORM 424(B)(3) | 0001683168-23-002546 | 333-227173 | 23832744 | 33 | 13845 | |||
| 2023-04-20 | 424B3 | FORM 424(B)(3) | 0001683168-23-002544 | 333-239779 | 23832737 | 33 | 13010 | |||
| 2023-04-20 | 8-K | CURRENT REPORT | 1.01,3.02,9.01 | 0001683168-23-002542 | 001-36304 | 23832727 | 34 | 939524 | 1 | 1 |
| 2023-04-19 | 424B5 | FORM 424(B)(5) | 0001683168-23-002531 | 333-256100 | 23830662 | 33 | 390188 | |||
| 2023-04-18 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001683168-23-002493 | 001-36304 | 23825509 | 34 | 220673 | 1 | 1 |
| 2023-04-17 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001683168-23-002488 | 001-36304 | 23824843 | 34 | 220984 | 1 | 1 |
| 2023-03-22 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001683168-23-001679 | 001-36304 | 23753631 | 34 | 257138 | 1 | 1 |
| 2023-03-22 | 10-K | FORM 10-K | 0001683168-23-001678 | 001-36304 | 23753592 | 34 | 5621497 | 1 | 1 | |
| 2023-03-10 | 8-K | FORM 8-K | 8.01 | 0001683168-23-001424 | 001-36304 | 23724652 | 34 | 197856 | 1 | 1 |
| 2023-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-015880 | 5113 | ||||||
| 2023-02-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-011942 | 5148 | ||||||
| 2023-02-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-011937 | 5143 | ||||||
| 2023-02-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-011932 | 5139 | ||||||
| 2023-02-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-011926 | 5125 | ||||||
| 2023-02-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-011920 | 5175 | ||||||
| 2023-02-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-011911 | 5014 | ||||||
| 2023-02-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-011909 | 5282 | ||||||
| 2023-02-22 | 8-K | FORM 8-K | 5.02,9.01 | 0001683168-23-001075 | 001-36304 | 23650538 | 34 | 342233 | 1 | 1 |
| 2023-02-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-010876 | 5275 | ||||||
| 2023-02-13 | 8-K | FORM 8-K | 8.01 | 0001683168-23-000781 | 001-36304 | 23614691 | 34 | 197999 | 1 | 1 |
| 2023-02-08 | SC 13G/A | AMENDMENT NO. 3 TO SCHEDULE 13G | 0001213900-23-009116 | 005-86901 | 23596947 | 34 | 67812 | |||
| 2023-01-25 | 8-K | FORM 8-K | 3.03,5.03,8.01,9.01 | 0001683168-23-000307 | 001-36304 | 23549904 | 34 | 247833 | 1 | 1 |
| 2023-01-06 | 8-K | FORM 8-K | 5.07,7.01,9.01 | 0001683168-23-000098 | 001-36304 | 23515770 | 34 | 1571720 | 1 | 1 |
| 2022-12-21 | 8-K | FORM 8-K | 8.01,9.01 | 0001683168-22-008584 | 001-36304 | 221478770 | 34 | 224049 | 1 | 1 |
| 2022-12-15 | 4 | FORM 4 SUBMISSION | 0001209191-22-061471 | 4882 | ||||||
| 2022-12-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-060358 | 4882 | ||||||
| 2022-12-06 | 4 | FORM 4 SUBMISSION | 0001209191-22-060009 | 4882 | ||||||
| 2022-12-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-059702 | 5228 | ||||||
| 2022-12-02 | DEFA14A | ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS | 0001683168-22-008171 | 001-36304 | 221442847 | 34 | 15615 | |||
| 2022-11-30 | DEF 14A | DEFINITIVE PROXY | 0001683168-22-008106 | 001-36304 | 221436086 | 34 | 481062 | |||
| 2022-11-29 | 4 | FORM 4 SUBMISSION | 0001209191-22-058942 | 6465 | ||||||
| 2022-11-28 | 4 | FORM 4 SUBMISSION | 0001209191-22-058862 | 4761 | ||||||
| 2022-11-23 | D | xslFormDX01/primary_doc.xml | 06b | 0001567619-22-020839 | 021-465775 | 221416268 | 33 | 9715 | ||
| 2022-11-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-057333 | 5252 | ||||||
| 2022-11-16 | 8-K | CURRENT REPORT | 1.01,3.02,3.03,5.03,9.01 | 0001683168-22-007821 | 001-36304 | 221395968 | 34 | 285934 | 1 | 1 |
| 2022-11-16 | PRE 14A | PRELIMINARY PROXY STATEMENT | 0001683168-22-007820 | 001-36304 | 221395876 | 34 | 481302 | |||
| 2022-11-10 | 8-K | FORM 8-K | 2.02,9.01 | 0001683168-22-007530 | 001-36304 | 221378385 | 34 | 265074 | 1 | 1 |
| 2022-11-10 | 10-Q | FORM 10-Q | 0001683168-22-007528 | 001-36304 | 221378298 | 34 | 3211128 | 1 | 1 | |
| 2022-10-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-051984 | 5034 | ||||||
| 2022-09-29 | 8-K | FORM 8-K | 5.02,9.01 | 0001683168-22-006665 | 001-36304 | 221277778 | 34 | 215127 | 1 | 1 |
| 2022-09-26 | 4 | FORM 4 SUBMISSION | 0001209191-22-051302 | 4860 | ||||||
| 2022-08-26 | 8-K | CURRENT REPORT | 3.01 | 0001683168-22-006086 | 001-36304 | 221205202 | 34 | 200554 | 1 | 1 |
| 2022-08-12 | 8-K | FORM 8-K | 5.07 | 0001683168-22-005634 | 001-36304 | 221160268 | 34 | 207032 | 1 | 1 |
| 2022-08-11 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001683168-22-005566 | 001-36304 | 221156767 | 34 | 262330 | 1 | 1 |
| 2022-08-11 | 10-Q | FORM 10-Q | 0001683168-22-005565 | 001-36304 | 221156631 | 34 | 3161078 | 1 | 1 | |
| 2022-06-30 | DEFA14A | DEFA14A | 0001683168-22-004729 | 001-36304 | 221058442 | 34 | 688272 | |||
| 2022-06-30 | DEF 14A | DEFINITIVE PROXY | 0001683168-22-004728 | 001-36304 | 221058376 | 34 | 563207 | |||
| 2022-05-12 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001683168-22-003517 | 001-36304 | 22918782 | 34 | 251001 | 1 | 1 |
| 2022-05-12 | 10-Q | FORM 10-Q | 0001683168-22-003516 | 001-36304 | 22918648 | 34 | 3064214 | 1 | 1 | |
| 2022-05-10 | 8-K | FORM 8-K | 5.02 | 0001683168-22-003391 | 001-36304 | 22910801 | 34 | 202612 | 1 | 1 |
| 2022-05-02 | 8-K | FORM 8-K | 5.01,5.03,9.01 | 0001683168-22-003069 | 001-36304 | 22879397 | 34 | 283919 | 1 | 1 |
| 2022-04-29 | 3 | FORM 3 SUBMISSION | 0001209191-22-026308 | 6315 | ||||||
| 2022-04-29 | 10-K/A | FORM 10-K AMENDMENT 1 | 0001683168-22-003052 | 001-36304 | 22876583 | 34 | 220850 | |||
| 2022-03-22 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001683168-22-001835 | 001-36304 | 22760541 | 34 | 253107 | 1 | 1 |
| 2022-03-22 | 10-K | FORM 10-K | 0001683168-22-001833 | 001-36304 | 22760477 | 34 | 5538775 | 1 | 1 | |
| 2022-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-015894 | 5116 | ||||||
| 2022-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-015893 | 5113 | ||||||
| 2022-03-03 | 8-K | CURRENT REPORT | 3.01,9.01 | 0001683168-22-001424 | 001-36304 | 22710266 | 34 | 260873 | 1 | 1 |
| 2022-02-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-010405 | 4987 | ||||||
| 2022-02-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-010402 | 5016 | ||||||
| 2022-02-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-010396 | 4982 | ||||||
| 2022-02-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-010391 | 4978 | ||||||
| 2022-02-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-010388 | 4976 | ||||||
| 2022-02-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-010384 | 5014 | ||||||
| 2022-02-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-010377 | 4964 | ||||||
| 2022-02-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-010372 | 5033 | ||||||
| 2022-02-11 | SC 13G/A | AMEDMENT NO. 2 TO SCHEDULE 13G | 0001213900-22-006700 | 005-86901 | 22616762 | 34 | 66942 | |||
| 2022-01-20 | SC 13G/A | PHIO PHARMACEUTICALS CORP. | 0000902664-22-000373 | 005-86901 | 22540986 | 34 | 77749 | |||
| 2021-12-21 | 25-NSE | xslF25X02/primary_doc.xml | 0001354457-21-001484 | 001-36304 | 211509344 | 34 | 3054 | |||
| 2021-11-10 | 8-K | FORM 8-K | 2.02,9.01 | 0001683168-21-005423 | 001-36304 | 211397347 | 34 | 260908 | 1 | 1 |
| 2021-11-10 | 10-Q | FORM 10-Q | 0001683168-21-005420 | 001-36304 | 211397171 | 34 | 3824659 | 1 | 1 | |
| 2021-08-17 | 4 | FORM 4 SUBMISSION | 0001209191-21-051759 | 4820 | ||||||
| 2021-08-12 | 8-K | FORM 8-K | 2.02,9.01 | 0001683168-21-003479 | 001-36304 | 211168645 | 34 | 259444 | 1 | 1 |
| 2021-08-12 | 10-Q | FORM 10-Q | 0001683168-21-003476 | 001-36304 | 211168515 | 34 | 3655332 | 1 | 1 | |
| 2021-06-21 | 8-K | FORM 8-K | 5.07 | 0001683168-21-002649 | 001-36304 | 211031367 | 34 | 27584 | ||
| 2021-05-21 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2021-05-21 17:00:00 | 9999999995-21-002069 | 333-256100 | 21950974 | 33 | 1824 | ||
| 2021-05-19 | CORRESP | filename1.htm | 0001683168-21-002113 | 6102 | ||||||
| 2021-05-19 | UPLOAD | filename1.pdf | 0000000000-21-006323 | 40344 | ||||||
| 2021-05-13 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001683168-21-001972 | 001-36304 | 21920673 | 34 | 70315 | ||
| 2021-05-13 | 10-Q | FORM 10-Q | 0001683168-21-001971 | 001-36304 | 21920661 | 34 | 2547811 | 1 | ||
| 2021-05-13 | S-3 | FORM S-3 | 0001683168-21-001968 | 333-256100 | 21920643 | 33 | 1566924 | |||
| 2021-05-06 | DEFA14A | DEFA14A | 0001683168-21-001801 | 001-36304 | 21898749 | 34 | 346430 | |||
| 2021-04-30 | DEF 14A | DEF 14A | 0001683168-21-001666 | 001-36304 | 21879290 | 34 | 604235 | |||
| 2021-03-25 | 8-K | FORM 8-K | 2.02,9.01 | 0001683168-21-001063 | 001-36304 | 21773529 | 34 | 75307 | ||
| 2021-03-25 | 10-K | FORM 10-K | 0001683168-21-001062 | 001-36304 | 21773520 | 34 | 3758647 | 1 | ||
| 2021-03-05 | 4 | FORM 4 SUBMISSION | 0001209191-21-018054 | 4819 | ||||||
| 2021-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-017573 | 5127 | ||||||
| 2021-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-017575 | 5063 | ||||||
| 2021-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-017574 | 5069 | ||||||
| 2021-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-017571 | 5074 | ||||||
| 2021-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-017570 | 5120 | ||||||
| 2021-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-017572 | 6606 | ||||||
| 2021-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-017569 | 6596 | ||||||
| 2021-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-017568 | 5178 | ||||||
| 2021-02-19 | SC 13G | PHIO PHARMACEUTICALS CORP. | 0000902664-21-001514 | 005-86901 | 21652974 | 34 | 83977 | |||
| 2021-02-17 | 8-K | FORM 8-K | 1.01,3.02,9.01 | 0001683168-21-000600 | 001-36304 | 21644934 | 34 | 348801 | ||
| 2021-02-17 | 424B5 | PROSPECTUS SUPPLEMENT | 0001683168-21-000593 | 333-224031 | 21642767 | 33 | 358454 | |||
| 2021-02-16 | SC 13G/A | SC 13G/A | 0001104659-21-023252 | 005-86901 | 21633771 | 34 | 59960 | |||
| 2021-02-16 | D | xslFormDX01/primary_doc.xml | 06b | 0001683168-21-000554 | 021-389435 | 21630175 | 33 | 13404 | ||
| 2021-02-09 | 424B2 | PROSPECTUS SUPPLEMENT | 0001683168-21-000437 | 333-252588 | 21603967 | 33 | 176134 | |||
| 2021-02-08 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2021-02-08 17:00:00 | 9999999995-21-000508 | 333-252588 | 21603768 | 33 | 1824 | ||
| 2021-02-05 | CORRESP | filename1.htm | 0001683168-21-000398 | 5976 | ||||||
| 2021-02-04 | S-3/A | FORM S-3 AMENDMENT 1 | 0001683168-21-000395 | 333-252588 | 21592362 | 33 | 60458 | |||
| 2021-02-02 | UPLOAD | filename1.pdf | 0000000000-21-001304 | 40341 | ||||||
| 2021-01-29 | S-3 | FORM S-3 REGISTRATION STATEMENT | 0001683168-21-000315 | 333-252588 | 21572476 | 33 | 280927 | |||
| 2021-01-29 | SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001213900-21-005111 | 005-86901 | 21567968 | 34 | 62262 | |||
| 2021-01-25 | 8-K | FORM 8-K | 1.01,3.02,9.01 | 0001683168-21-000249 | 001-36304 | 21550738 | 34 | 617969 | ||
| 2021-01-05 | SC 13G/A | SABBY 13G-A PHIO 1.05.21 | 0001535610-21-000011 | 005-86901 | 21503916 | 34 | 13401 | |||
| 2020-12-23 | S-8 | REGISTRATION STATEMENT | 0001683168-20-004444 | 333-251670 | 201413527 | 33 | 258970 | |||
| 2020-11-10 | 8-K | FORM 8-K | 2.02,9.01 | 0001683168-20-003810 | 001-36304 | 201301963 | 34 | 75481 | ||
| 2020-11-10 | 10-Q | QUARTERLY REPORT | 0001683168-20-003809 | 001-36304 | 201301952 | 34 | 2477985 | 1 | ||
| 2020-10-13 | 8-K | FORM 8-K | 5.03,5.07,9.01 | 0001683168-20-003428 | 001-36304 | 201236666 | 34 | 91801 | ||
| 2020-08-28 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001683168-20-002904 | 001-36304 | 201148610 | 34 | 397765 | |||
| 2020-08-28 | DEF 14A | DEFINITIVE PROXY STATEMENT | 0001683168-20-002903 | 001-36304 | 201148591 | 34 | 827700 | |||
| 2020-08-19 | 4 | FORM 4 SUBMISSION | 0001209191-20-047533 | 4820 | ||||||
| 2020-08-12 | 8-K | FORM 8-K | 2.02,9.01 | 0001683168-20-002650 | 001-36304 | 201096118 | 34 | 84273 | ||
| 2020-08-12 | 10-Q | FORM 10-Q | 0001683168-20-002649 | 001-36304 | 201096078 | 34 | 2554388 | 1 | ||
| 2020-07-20 | 424B3 | 424B3 | 0001683168-20-002318 | 333-239779 | 201037000 | 33 | 131500 | |||
| 2020-07-17 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2020-07-17 16:30:00 | 9999999995-20-001854 | 333-239779 | 201034921 | 33 | 1825 | ||
| 2020-07-15 | UPLOAD | filename1.pdf | 0000000000-20-006458 | 40257 | ||||||
| 2020-07-15 | CORRESP | filename1.htm | 0001683168-20-002284 | 6028 | ||||||
| 2020-07-09 | S-1 | FORM S-1 | 0001683168-20-002231 | 333-239779 | 201021166 | 33 | 264122 | |||
| 2020-06-02 | 424B3 | PROSPECTUS | 0001683168-20-001823 | 333-238204 | 20937895 | 33 | 133657 | |||
| 2020-06-01 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2020-06-01 16:30:00 | 9999999995-20-001301 | 333-238204 | 20935504 | 33 | 1824 | ||
| 2020-05-29 | CORRESP | filename1.htm | 0001683168-20-001784 | 6150 | ||||||
| 2020-05-28 | CORRESP | filename1.htm | 0001683168-20-001773 | 40929 | ||||||
| 2020-05-28 | S-1/A | AMENDMENT NO. 1 | 0001683168-20-001772 | 333-238204 | 20922312 | 33 | 251280 | |||
| 2020-05-21 | UPLOAD | filename1.pdf | 0000000000-20-004567 | 45479 | ||||||
| 2020-05-12 | S-1 | FORM S-1 | 0001683168-20-001524 | 333-238204 | 20870016 | 33 | 264328 | |||
| 2020-05-12 | 8-K | FORM 8-K | 2.01,9.01 | 0001683168-20-001520 | 001-36304 | 20869583 | 34 | 74481 | ||
| 2020-05-12 | 10-Q | FORM 10-Q FOR MARCH 31, 2020 | 0001683168-20-001519 | 001-36304 | 20869582 | 34 | 2299597 | 1 | ||
| 2020-04-14 | D | xslFormDX01/primary_doc.xml | 06b | 0001683168-20-001189 | 021-364970 | 20791942 | 33 | 13370 | ||
| 2020-04-09 | SC 13G | SC 13G | 0001104659-20-044916 | 005-86901 | 20783441 | 34 | 105478 | |||
| 2020-04-08 | SC 13G | d8515987_13-g.htm | 0000919574-20-002821 | 005-86901 | 20782346 | 34 | 117551 | |||
| 2020-04-02 | 8-K | CURRENT REPORT | 1.01,3.02,9.01 | 0001683168-20-001071 | 001-36304 | 20769955 | 34 | 600749 | ||
| 2020-04-01 | 424B5 | PROSPECTUS SUPPLEMENT | 0001683168-20-001063 | 333-224031 | 20766097 | 33 | 341399 | |||
| 2020-03-26 | 8-K | FORM 8-K | 2.02,9.01 | 0001683168-20-000971 | 001-36304 | 20747085 | 34 | 83210 | ||
| 2020-03-26 | 10-K | FORM 10-K | 0001683168-20-000969 | 001-36304 | 20747078 | 34 | 3642724 | 1 | ||
| 2020-03-12 | 8-K | FORM 8-K | 8.01,9.01 | 0001683168-20-000783 | 001-36304 | 20708939 | 34 | 37421 | ||
| 2020-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-20-015801 | 5252 | ||||||
| 2020-02-28 | S-8 | FORM S-8 REGISTRATION STATEMENT | 0001683168-20-000630 | 333-236784 | 20672244 | 33 | 51869 | |||
| 2020-02-24 | D | xslFormDX01/primary_doc.xml | 06b | 0001683168-20-000567 | 021-361241 | 20645698 | 33 | 13282 | ||
| 2020-02-14 | SC 13G | d8477433_13g.htm | 0000919574-20-001615 | 005-86901 | 20618298 | 34 | 107901 | |||
| 2020-02-13 | 8-K | FORM 8-K | 1.01,8.01,9.01 | 0001683168-20-000483 | 001-36304 | 20612172 | 34 | 739638 | ||
| 2020-02-13 | SC 13G | SCHEDULE 13G | 0001213900-20-003677 | 005-86901 | 20612143 | 34 | 121412 | |||
| 2020-02-12 | 424B4 | 424B4 | 0001683168-20-000451 | 333-234032 | 20605551 | 33 | 325639 | |||
| 2020-02-11 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2020-02-11 09:00:00 | 9999999995-20-000314 | 333-234032 | 20599558 | 33 | 1824 | ||
| 2020-02-11 | SC 13G | SABBY 13G PHIO 2.11.20 | 0001535610-20-000069 | 005-86901 | 20595569 | 34 | 13393 | |||
| 2020-02-10 | SC 13G/A | SC 13G/A | 0001104659-20-013419 | 005-86901 | 20591623 | 34 | 88056 | |||
| 2020-02-10 | 8-K | FORM 8-K | 8.01 | 0001683168-20-000420 | 001-36304 | 20589590 | 34 | 19344 | ||
| 2020-02-07 | CORRESP | filename1.htm | 0001683168-20-000392 | 10985 | ||||||
| 2020-02-07 | CORRESP | filename1.htm | 0001683168-20-000391 | 6317 | ||||||
| 2020-02-07 | S-1/A | AMENDMENT NO. 2 TO REGISTRATION STATEMENT | 0001683168-20-000390 | 333-234032 | 20586820 | 33 | 505213 | |||
| 2020-02-06 | 8-K | FORM 8-K | 1.01,3.02,9.01 | 0001683168-20-000378 | 001-36304 | 20583495 | 34 | 397843 | ||
| 2020-02-06 | 424B5 | PROSPECTUS SUPPLEMENT | 0001683168-20-000372 | 333-224031 | 20580728 | 33 | 353903 | |||
| 2020-01-31 | S-1/A | AMENDMENT #1 TO REGISTRATION STATEMENT | 0001683168-20-000317 | 333-234032 | 20566172 | 33 | 1103060 | |||
| 2020-01-22 | SC 13G/A | SABBY 13G-A PHIO 1.22.20 | 0001535610-20-000054 | 005-86901 | 20538111 | 34 | 13449 | |||
| 2020-01-14 | 8-K | FORM 8-K | 3.03,5.03,8.01,9.01 | 0001683168-20-000141 | 001-36304 | 20526528 | 34 | 51515 | ||
| 2020-01-10 | 8-K | FORM 8-K | 5.07 | 0001683168-20-000082 | 001-36304 | 20522007 | 34 | 18877 | ||
| 2019-12-18 | 8-K | FORM 8-K | 8.01 | 0001683168-19-004008 | 001-36304 | 191291263 | 34 | 20139 | ||
| 2019-12-13 | DEFA14A | ADDITIONAL PROXY MATERIALS | 0001683168-19-003967 | 001-36304 | 191284908 | 34 | 31198 | |||
| 2019-12-13 | DEFA14A | NOTICE AND PROXY STATEMENT | 0001683168-19-003961 | 001-36304 | 191283451 | 34 | 34062 | |||
| 2019-12-06 | 8-K/A | FORM 8-K AMENDMENT | 3.01,9.01 | 0001683168-19-003908 | 001-36304 | 191273796 | 34 | 40114 | ||
| 2019-11-22 | DEF 14A | DEFINITIVE PROXY | 0001683168-19-003804 | 001-36304 | 191242596 | 34 | 335482 |
One latest value per concept from companyfacts (360 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 11.95M | 2026-11-03 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 11.20M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 564,494 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-08-14 | 0001437749-26-027997 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 599,704 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-08-14 | 0001437749-26-027997 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 885,952 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-08-14 | 0001437749-26-027997 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 1.16M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-08-14 | 0001437749-26-027997 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 19.33 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-08-14 | 0001437749-26-027997 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 212.33 | 2026-09-25 | S-8 | 2026-09-28 | 0001437749-26-031367 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 212.33 | 2026-09-25 | S-8 | 2026-09-28 | 0001437749-26-031367 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 1.54M | 2026-09-25 | S-8 | 2026-09-28 | 0001437749-26-031367 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-09-25 | S-8 | 2026-09-28 | 0001437749-26-031367 | |||
| us-gaap | AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent | Accounts Payable and Accrued Liabilities | USD | 2.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 886,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 | |
| us-gaap | AccountsPayableTradeCurrentAndNoncurrent | Accounts Payable, Trade | USD | 886,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | -35,000 | 2003-01-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-13 | 0001193125-12-467372 |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 1.81M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 39,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 | |
| us-gaap | AccruedProfessionalFeesCurrentAndNoncurrent | Accrued Professional Fees | USD | 133,000 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-07 | 0001437749-26-015604 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 228,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 175.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 11.01M | 2012-06-30 | 2012 | Q2 | 10-Q | 2012-08-14 | 0001193125-12-355540 | |
| us-gaap | AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation | USD | 107,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings | Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings | USD | -209,000 | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-30 | 0001193125-17-102730 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalOther | Adjustments to Additional Paid in Capital, Other | USD | 699,000 | 2012-01-01 | 2012-12-31 | 2013 | FY | 10-K | 2014-03-28 | 0001193125-14-121519 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition | USD | 13,000 | 2015-01-01 | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-08-12 | 0001193125-15-287233 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 285,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition | USD | 491,000 | 2014-01-01 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-14 | 0001193125-14-198000 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 435,000 | 2025-07-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockSplit | Adjustments to Additional Paid in Capital, Stock Split | USD | 1,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 13,000 | 2012-01-01 | 2012-12-31 | 2013 | FY | 10-K | 2014-03-28 | 0001193125-14-121519 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 881,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |
| us-gaap | AmortizationOfLeasedAsset | Amortization of Leased Asset | USD | 9,000 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-28 | 0001193125-14-121519 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 14.45M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-27 | 0001683168-19-000795 |
| us-gaap | Assets | Assets | USD | 11.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 11.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 16.05M | 2013-06-30 | 2013 | Q2 | 10-Q | 2013-08-14 | 0001193125-13-333766 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 0 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-13 | 0001683168-21-001971 |
| us-gaap | CapitalLeasedAssetsGross | Capital Leased Assets, Gross | USD | 26,000 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-28 | 0001193125-14-121519 | |
| us-gaap | CapitalLeaseObligations | Capital Lease Obligations | USD | 0 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-28 | 0001193125-14-121519 | |
| us-gaap | CapitalLeaseObligationsCurrent | Capital Lease Obligations, Current | USD | 5,000 | 2012-12-31 | 2013 | FY | 10-K | 2014-03-28 | 0001193125-14-121519 | |
| us-gaap | CapitalLeaseObligationsIncurred | Lease Obligation Incurred | USD | 620,000 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-26 | 0001683168-20-000969 |
| us-gaap | CapitalLeaseObligationsNoncurrent | Capital Lease Obligations, Noncurrent | USD | 5,000 | 2011-12-31 | 2012 | FY | 10-K | 2013-03-29 | 0001193125-13-133515 | |
| us-gaap | CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation | Capital Leases, Lessee Balance Sheet, Assets by Major Class, Accumulated Depreciation | USD | 26,000 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-28 | 0001193125-14-121519 | |
| us-gaap | Cash | Cash | USD | 6.47M | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-09 | 0001683168-24-003175 | |
| us-gaap | CashAcquiredFromAcquisition | Cash Acquired from Acquisition | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-27 | 0001683168-19-000795 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 10.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 | |
| us-gaap | CashAndCashEquivalentsFairValueDisclosure | Cash and Cash Equivalents, Fair Value Disclosure | USD | 5.39M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-14 | 0001683168-24-008120 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | 7.79M | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-30 | 0001193125-17-102730 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 10.78M | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-14 | 0001683168-25-006174 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 10.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | 5.39M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-14 | 0001683168-25-006174 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -10.42M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |
| us-gaap | CashFDICInsuredAmount | Cash, FDIC Insured Amount | USD | 250,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 | |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 2.3 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 13.36M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 801.36M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-29 | 0001193125-13-133515 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 100.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 11.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 11.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 1,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 | |
| us-gaap | ContractualObligation | Contractual Obligation | USD | 400,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 | |
| us-gaap | ContractualObligationDueAfterFifthYear | Contractual Obligation, to be Paid, after Year Five | USD | 100,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0001683168-24-002021 | |
| us-gaap | ContractualObligationDueInFifthYear | Contractual Obligation, to be Paid, Year Five | USD | 100,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 | |
| us-gaap | ContractualObligationDueInFourthYear | Contractual Obligation, to be Paid, Year Four | USD | 100,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 | |
| us-gaap | ContractualObligationDueInNextTwelveMonths | Contractual Obligation, to be Paid, Year One | USD | 100,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 | |
| us-gaap | ContractualObligationDueInSecondYear | Contractual Obligation, to be Paid, Year Two | USD | 100,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 | |
| us-gaap | ContractualObligationDueInThirdYear | Contractual Obligation, to be Paid, Year Three | USD | 100,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 | |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 3.52M | 2017-01-01 | 2017-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001193125-18-158327 |
| us-gaap | ConvertibleLongTermNotesPayable | Convertible Notes Payable, Noncurrent | USD | 500,000 | 2011-12-31 | 2012 | FY | 10-K | 2013-03-29 | 0001193125-13-133515 | |
| us-gaap | ConvertiblePreferredStockSharesIssuedUponConversion | Convertible Preferred Stock, Shares Issued upon Conversion | shares | 1,111.11 | 2016-12-21 | 2016 | FY | 10-K | 2017-03-30 | 0001193125-17-102730 | |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | DebtConversionConvertedInstrumentAmount1 | Debt Conversion, Converted Instrument, Amount | USD | 1.00M | 2012-01-01 | 2012-12-31 | 2013 | FY | 10-K | 2014-03-28 | 0001193125-14-121519 |
| us-gaap | DebtConversionConvertedInstrumentSharesIssued1 | Debt Conversion, Converted Instrument, Shares Issued | shares | 9,500 | 2012-04-01 | 2012-04-27 | 2012 | FY | 10-K | 2013-03-29 | 0001193125-13-133515 |
| us-gaap | DebtConversionOriginalDebtAmount1 | Debt Conversion, Original Debt, Amount | USD | 1.00M | 2012-04-01 | 2012-04-27 | 2012 | FY | 10-K | 2013-03-29 | 0001193125-13-133515 |
| us-gaap | DebtInstrumentConvertibleConversionPrice1 | Debt Instrument, Convertible, Conversion Price | USD/shares | 1,000 | 2011-09-24 | 2012 | FY | 10-K | 2013-03-29 | 0001193125-13-133515 | |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | 2.25M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | DeferredFederalStateAndLocalTaxExpenseBenefit | Deferred Federal, State and Local, Tax Expense (Benefit) | USD | 2.61M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-27 | 0001683168-19-000795 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 17,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 | |
| us-gaap | DeferredRevenue | Deferred Revenue | USD | 27,000 | 2012-12-31 | 2013 | FY | 10-K | 2014-03-28 | 0001193125-14-121519 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 47,000 | 2014-12-31 | 2015 | FY | 10-K | 2016-03-30 | 0001193125-16-523721 | |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | 358,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 3,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 2.63M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 1.99M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 98,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 212,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 248,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 84,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseOther | Deferred Tax Assets, Tax Deferred Expense, Other | USD | 2,000 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-26 | 0001683168-20-000969 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 2.61M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 | |
| us-gaap | DeferredTaxLiabilitiesLeasingArrangements | Deferred Tax Liabilities, Leasing Arrangements | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 | |
| us-gaap | DeferredTaxLiabilitiesOther | Deferred Tax Liabilities, Other | USD | 17,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 | |
| us-gaap | DepositsAssetsNoncurrent | Deposits Assets, Noncurrent | USD | 18,000 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-14 | 0001193125-14-198000 | |
| us-gaap | Depreciation | Depreciation | USD | 2,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 75.00M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-22 | 0001683168-22-001833 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 4,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |
| us-gaap | DerivativeFairValueOfDerivativeLiability | Derivative Liability, Fair Value, Gross Liability | USD | 8.72M | 2011-09-24 | 2012 | FY | 10-K | 2013-03-29 | 0001193125-13-133515 | |
| us-gaap | DerivativeLiabilityFairValueNet1 | Derivative Liability, Fair Value, Net (Deprecated 2013-01-31) | USD | 3.14M | 2010-12-31 | 2012 | FY | 10-K | 2013-03-29 | 0001193125-13-133515 | |
| us-gaap | DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) | USD | 40.37M | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-14 | 0001193125-14-198000 | |
| us-gaap | DividendsPreferredStock | Dividends, Preferred Stock | USD | 126,000 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-30 | 0001193125-16-523721 |
| us-gaap | DividendsPreferredStockPaidinkind | Dividends, Preferred Stock, Paid-in-kind | USD | 104,000 | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-30 | 0001193125-17-102730 |
| us-gaap | DividendsPreferredStockStock | Dividends, Preferred Stock, Stock | USD | -6.90M | 2013-01-01 | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-11-14 | 0001193125-13-441091 |
| us-gaap | DueFromAffiliateCurrent | Due from Affiliate, Current | USD | 597,000 | 2011-12-31 | 2012 | FY | 10-K | 2013-03-29 | 0001193125-13-133515 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -1.06 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -1.04 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-22 | 0001683168-22-001833 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.86 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-14 | 0001683168-25-006174 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.229 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-27 | 0001683168-19-000795 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | pure | -0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent | pure | -0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.106 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | -0.021 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | EmployeeBenefitsAndShareBasedCompensation | Employee Benefits and Share-based Compensation | USD | 99,000 | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-15 | 0001683168-25-003719 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 31,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 | |
| us-gaap | EmployeeRelatedLiabilitiesCurrentAndNoncurrent | Employee-related Liabilities | USD | 422,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 157,000 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-26 | 0001193125-18-096053 | |
| us-gaap | EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense | Share-based Payment Arrangement, Expense, Tax Benefit | USD | 0 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-26 | 0001193125-18-096053 |
| us-gaap | FairValueAssetsLevel1ToLevel2TransfersAmount | Fair Value, Assets, Level 1 to Level 2 Transfers, Amount | USD | 0 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-30 | 0001193125-17-102730 | |
| us-gaap | FairValueAssetsLevel2ToLevel1TransfersAmount | Fair Value, Assets, Level 2 to Level 1 Transfers, Amount | USD | 0 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-30 | 0001193125-17-102730 | |
| us-gaap | FairValueOfAssetsAcquired | Fair Value of Assets Acquired | USD | 2.74M | 2017-01-01 | 2017-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001193125-18-158327 |
| us-gaap | FurnitureAndFixturesGross | Furniture and Fixtures, Gross | USD | 8,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 | |
| us-gaap | GainLossOnDispositionOfAssets | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property | USD | 6,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | 3,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-22 | 0001683168-23-001678 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 3.77M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |
| us-gaap | GrantsReceivable | Grants Receivable | USD | 800,000 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-29 | 0001193125-13-133515 | |
| us-gaap | HeldToMaturitySecuritiesCurrent | Debt Securities, Held-to-maturity, Current | USD | 5.50M | 2015-12-31 | 2016 | FY | 10-K | 2017-03-30 | 0001193125-17-102730 | |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -11.48M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-22 | 0001683168-23-001678 |
| us-gaap | IncomeTaxExaminationPenaltiesAndInterestAccrued | Income Tax Examination, Penalties and Interest Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 | |
| us-gaap | IncomeTaxExaminationPenaltiesAndInterestExpense | Income Tax Examination, Penalties and Interest Expense | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 1.99M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -1.83M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount | USD | 10,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | IncomeTaxReconciliationOtherReconcilingItems | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount | USD | 3,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | IncomeTaxReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Amount | USD | 179,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 451,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 906,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | -47,000 | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-30 | 0001193125-17-102730 |
| us-gaap | IncreaseDecreaseInDerivativeAssetsAndLiabilities | Increase (Decrease) in Derivative Assets and Liabilities | USD | -2.61M | 2011-01-01 | 2011-09-24 | 2012 | FY | 10-K | 2013-03-29 | 0001193125-13-133515 |
| us-gaap | IncreaseDecreaseInDueToOtherRelatedPartiesCurrent | Increase (Decrease) in Due to Other Related Parties, Current | USD | 597,000 | 2012-01-01 | 2012-12-31 | 2013 | FY | 10-K | 2014-03-28 | 0001193125-14-121519 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 256,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |
| us-gaap | IncreaseDecreaseInPrepaidExpense | Increase (Decrease) in Prepaid Expense | USD | -46,000 | 2016-01-01 | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-05-12 | 0001193125-16-588016 |
| us-gaap | IncreaseDecreaseInRestrictedCash | Increase (Decrease) in Restricted Cash | USD | -3,000 | 2013-01-01 | 2013-12-31 | 2014 | FY | 10-K | 2015-03-30 | 0001193125-15-110334 |
| us-gaap | InterestAndOtherIncome | Interest and Other Income | USD | 6,000 | 2014-01-01 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-14 | 0001193125-14-198000 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | -125,000 | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-15 | 0001683168-25-003719 |
| us-gaap | InterestIncomeExpenseNet | Interest Income (Expense), Net | USD | 231,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 |
| us-gaap | InterestIncomeExpenseNonoperatingNet | Interest Income (Expense), Nonoperating, Net | USD | -9,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-22 | 0001683168-22-001833 |
| us-gaap | InterestPaid | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | USD | 3,000 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-27 | 0001683168-19-000795 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | InvestmentIncomeNet | Investment Income, Net | USD | 395,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |
| us-gaap | IssuanceOfStockAndWarrantsForServicesOrClaims | Issuance of Stock and Warrants for Services or Claims | USD | 71,000 | 2014-01-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-13 | 0001193125-14-410208 |
| us-gaap | LeaseAndRentalExpense | Operating Leases, Rent Expense | USD | 115,000 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-26 | 0001193125-18-096053 |
| us-gaap | LeaseCost | Lease, Cost | USD | 102,000 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-26 | 0001683168-20-000969 |
| us-gaap | LeaseholdImprovementsGross | Leasehold Improvements, Gross | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 35,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0001683168-24-002021 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 35,000 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001683168-19-003526 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 35,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0001683168-24-002021 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 35,000 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-10 | 0001683168-20-003809 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 35,000 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-25 | 0001683168-21-001062 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 35,000 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001683168-22-003516 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 35,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-22 | 0001683168-23-001678 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 36,000 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0001683168-23-007809 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0001683168-24-002021 | |
| us-gaap | Liabilities | Liabilities | USD | 2.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 11.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 1.21M | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-14 | 0001683168-25-006174 | |
| us-gaap | LiabilityForUncertainTaxPositionsCurrent | Liability for Uncertainty in Income Taxes, Current | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-22 | 0001683168-22-001833 | |
| us-gaap | LossContingencyAccrualAtCarryingValue | Loss Contingency Accrual | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 | |
| us-gaap | LossContingencyLossInPeriod | Loss Contingency, Loss in Period | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 |
| us-gaap | MachineryAndEquipmentGross | Machinery and Equipment, Gross | USD | 265,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | -107,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | 932,000 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001193125-18-158327 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 3,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | 98,000 | 2017-01-01 | 2017-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001193125-18-158327 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -10.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | -1.91M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001193125-18-158327 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -12.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -12.45M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-26 | 0001193125-18-096053 |
| us-gaap | NoncashOrPartNoncashAcquisitionPayablesAssumed1 | Noncash or Part Noncash Acquisition, Payables Assumed | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-27 | 0001683168-19-000795 |
| us-gaap | NoninterestExpenseOfferingCost | Noninterest Expense Offering Cost | USD | 1.28M | 2025-01-01 | 2025-03-31 | 2025 | Q2 | 10-Q | 2025-08-14 | 0001683168-25-006174 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 246,000 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-14 | 0001683168-25-006174 |
| us-gaap | NotesAndLoansReceivableNetNoncurrent | Financing Receivable, after Allowance for Credit Loss, Noncurrent | USD | 150,000 | 2016-12-31 | 2017 | Q1 | 10-Q/A | 2018-03-26 | 0001193125-18-095994 | |
| us-gaap | NotesReduction | Notes Reduction | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-27 | 0001683168-19-000795 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | pure | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | pure | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 12.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -12.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 16,800 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-14 | 0001683168-25-006174 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 2,700 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 30,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-27 | 0001683168-19-000795 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 30,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-27 | 0001683168-19-000795 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 30,000 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-30 | 0001193125-15-110334 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 30,000 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-30 | 0001193125-16-523721 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 30,000 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-30 | 0001193125-17-102730 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 30,000 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-26 | 0001193125-18-096053 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 0 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-30 | 0001193125-15-110334 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsReceivable | Operating Leases, Future Minimum Payments Receivable | USD | 70,000 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-29 | 0001193125-13-133515 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsReceivableCurrent | Operating Leases, Future Minimum Payments Receivable, Current | USD | 57,000 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-29 | 0001193125-13-133515 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears | Operating Leases, Future Minimum Payments Receivable, in Two Years | USD | 13,000 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-29 | 0001193125-13-133515 | |
| us-gaap | OperatingLeasesRentExpenseNet | Operating Leases, Rent Expense, Net | USD | 127,000 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-26 | 0001683168-20-000969 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 | |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 46.80M | 2014-12-31 | 2014 | FY | 10-K | 2015-03-30 | 0001193125-15-110334 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 17,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 | |
| us-gaap | OtherAssets | Other Assets | USD | 2,000 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-13 | 0001193125-12-467372 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 | |
| us-gaap | OtherGeneralAndAdministrativeExpense | Other General and Administrative Expense | USD | 473,000 | 2013-01-01 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-15 | 0001193125-13-220846 |
| us-gaap | OtherIncome | Other Income | USD | 6,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 |
| us-gaap | OtherNoncashExpense | Other Noncash Expense | USD | 109,000 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-26 | 0001683168-20-000969 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 7,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |
| us-gaap | OtherResearchAndDevelopmentExpense | Other Research and Development Expense | USD | 0 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001683168-22-007528 |
| us-gaap | PaymentOfFinancingAndStockIssuanceCosts | Payment of Financing and Stock Issuance Costs | USD | 52,000 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001683168-19-003526 |
| us-gaap | PaymentsForProceedsFromOtherInvestingActivities | Payments for (Proceeds from) Other Investing Activities | USD | 18,000 | 2013-01-01 | 2013-12-31 | 2014 | FY | 10-K | 2015-03-30 | 0001193125-15-110334 |
| us-gaap | PaymentsForRent | Payments for Rent | USD | 10,300 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-27 | 0001683168-19-000795 |
| us-gaap | PaymentsForRepurchaseOfRedeemablePreferredStock | Payments for Repurchase of Redeemable Preferred Stock | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 |
| us-gaap | PaymentsOfCapitalDistribution | Payments of Capital Distribution | USD | 12,000 | 2013-01-01 | 2013-12-31 | 2014 | FY | 10-K | 2015-03-30 | 0001193125-15-110334 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 0 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-10 | 0001683168-20-003809 |
| us-gaap | PaymentsRelatedToTaxWithholdingForShareBasedCompensation | Payment, Tax Withholding, Share-based Payment Arrangement | USD | 107,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |
| us-gaap | PaymentsToAcquireBusinessesNetOfCashAcquired | Payments to Acquire Businesses, Net of Cash Acquired | USD | -100,000 | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q/A | 2018-03-26 | 0001193125-18-095994 |
| us-gaap | PaymentsToAcquireNotesReceivable | Payments to Acquire Notes Receivable | USD | 150,000 | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-26 | 0001193125-18-096053 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |
| us-gaap | PaymentsToAcquireShortTermInvestments | Payments to Acquire Short-term Investments | USD | 2.00M | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-26 | 0001193125-18-096053 |
| us-gaap | PreferredStockConversionsInducements | Preferred Stock Conversions, Inducements | USD | 4.00M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 |
| us-gaap | PreferredStockDividendsAndOtherAdjustments | Preferred Stock Dividends and Other Adjustments | USD | 3.67M | 2014-01-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-13 | 0001193125-14-410208 |
| us-gaap | PreferredStockDividendsIncomeStatementImpact | Preferred Stock Dividends, Income Statement Impact | USD | 2.08M | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-26 | 0001193125-18-096053 |
| us-gaap | PreferredStockLiquidationPreferenceValue | Preferred Stock, Liquidation Preference, Value | USD | 0 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-28 | 0001193125-14-121519 | |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 | |
| us-gaap | PreferredStockRedemptionDiscount | Preferred Stock Redemption Discount | USD | 9.50M | 2012-01-01 | 2012-12-31 | 2013 | FY | 10-K | 2014-03-28 | 0001193125-14-121519 |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 701,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 843,000 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001683168-22-007528 | |
| us-gaap | ProceedsFromContributionsFromParent | Proceeds from Contributions from Parent | USD | 699,000 | 2012-01-01 | 2012-12-31 | 2013 | FY | 10-K | 2014-03-28 | 0001193125-14-121519 |
| us-gaap | ProceedsFromConvertibleDebt | Proceeds from Convertible Debt | USD | 500,000 | 2012-01-01 | 2012-12-31 | 2013 | FY | 10-K | 2014-03-28 | 0001193125-14-121519 |
| us-gaap | ProceedsFromInterestReceived | Proceeds from Interest Received | USD | 724,000 | 2003-01-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-13 | 0001193125-12-467372 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 0 | 2019-01-01 | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-14 | 0001683168-19-001519 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 8.50M | 2012-01-01 | 2012-12-31 | 2013 | FY | 10-K | 2014-03-28 | 0001193125-14-121519 |
| us-gaap | ProceedsFromIssuanceOfDebt | Proceeds from Issuance of Debt | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-22 | 0001683168-22-001833 |
| us-gaap | ProceedsFromIssuanceOfRedeemablePreferredStock | Proceeds from Issuance of Redeemable Preferred Stock | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0001683168-24-002021 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised | USD | 1,000 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-25 | 0001683168-21-001062 |
| us-gaap | ProceedsFromIssuanceOrSaleOfEquity | Proceeds from Issuance or Sale of Equity | USD | 20.60M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | ProceedsFromOtherEquity | Proceeds from Other Equity | USD | 6.49M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-14 | 0001683168-25-006174 |
| us-gaap | ProceedsFromPaymentsForOtherFinancingActivities | Proceeds from (Payments for) Other Financing Activities | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-22 | 0001683168-22-001833 |
| us-gaap | ProceedsFromSaleMaturityAndCollectionsOfInvestments | Proceeds from Sale, Maturity and Collection of Investments | USD | 7.50M | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-26 | 0001193125-18-096053 |
| us-gaap | ProceedsFromSaleOfOtherProductiveAssets | Proceeds from Sale of Other Productive Assets | USD | 9,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 |
| us-gaap | ProceedsFromSaleOfProductiveAssets | Proceeds from Sale of Productive Assets | USD | 3,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 12,000 | 2014-01-01 | 2014-12-31 | 2015 | FY | 10-K | 2016-03-30 | 0001193125-16-523721 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 5,000 | 2013-01-01 | 2013-12-31 | 2014 | FY | 10-K | 2015-03-30 | 0001193125-15-110334 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 239,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 7,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 | |
| us-gaap | PropertyPlantAndEquipmentOther | Property, Plant and Equipment, Other, Gross | USD | 35,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 | |
| us-gaap | PropertyPlantAndEquipmentOwnedAccumulatedDepreciation | Property, Plant, and Equipment, Owned, Accumulated Depreciation | USD | 585,000 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-29 | 0001193125-13-133515 | |
| us-gaap | PropertyPlantAndEquipmentTransfersAndChanges | Property, Plant and Equipment, Transfers and Changes | USD | 126,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0001683168-24-002021 |
| us-gaap | ReclassificationsOfTemporaryToPermanentEquity | Reclassifications of Temporary to Permanent Equity | USD | 2.00M | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-30 | 0001193125-17-102730 |
| us-gaap | RepaymentsOfDebtAndCapitalLeaseObligations | Repayments of Debt and Lease Obligation | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-22 | 0001683168-22-001833 |
| us-gaap | RepaymentsOfLongTermCapitalLeaseObligations | Repayments of Long-term Capital Lease Obligations | USD | 5,000 | 2013-01-01 | 2013-12-31 | 2014 | FY | 10-K | 2015-03-30 | 0001193125-15-110334 |
| us-gaap | RepaymentsOfNotesPayable | Repayments of Notes Payable | USD | 6,000 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-26 | 0001683168-20-000969 |
| us-gaap | ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff | Research and Development Asset Acquired Other than Through Business Combination, Written-off | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-27 | 0001683168-19-000795 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 8.94M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |
| us-gaap | ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost | Research and Development Expense (Excluding Acquired in Process Cost) | USD | 1.10M | 2013-01-01 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-15 | 0001193125-13-220846 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 0 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-14 | 0001683168-24-008120 | |
| us-gaap | RestrictedCashAndCashEquivalents | Restricted Cash and Cash Equivalents | USD | 50,000 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-26 | 0001193125-18-096053 | |
| us-gaap | RestrictedCashAndCashEquivalentsAtCarryingValue | Restricted Cash and Cash Equivalents, Current | USD | 50,000 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001193125-18-158327 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -167.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 | |
| us-gaap | RevenueFromGrants | Revenue from Grants (Deprecated 2018-01-31) | USD | 34,000 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-30 | 0001193125-16-523721 |
| us-gaap | Revenues | Revenues | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-25 | 0001683168-21-001062 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-25 | 0001683168-21-001062 |
| us-gaap | SalesRevenueNet | Revenue, Net (Deprecated 2018-01-31) | USD | 57,000 | 2003-01-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-13 | 0001193125-12-467372 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 881,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 2.04 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-28 | 0001193125-14-121519 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 1.137 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 0.915 | 2018-01-01 | 2018-03-31 | 2019 | Q1 | 10-Q | 2019-05-14 | 0001683168-19-001519 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 0.913 | 2018-01-01 | 2018-03-31 | 2019 | Q1 | 10-Q | 2019-05-14 | 0001683168-19-001519 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.047 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.028 | 2018-01-01 | 2018-03-31 | 2019 | Q1 | 10-Q | 2019-05-14 | 0001683168-19-001519 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.027 | 2018-01-01 | 2018-03-31 | 2019 | Q1 | 10-Q | 2019-05-14 | 0001683168-19-001519 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate | pure | 0.989 | 2019-01-01 | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-14 | 0001683168-19-001519 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | shares | 750,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-27 | 0001683168-19-000795 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | shares | 470,803 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-27 | 0001683168-19-000795 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 0 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-13 | 0001437749-25-034857 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 1,121 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 614.6 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 0 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-30 | 0001193125-15-110334 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | shares | 5 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | shares | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 0 | 2025-01-01 | 2025-06-30 | 2026 | Q2 | 10-Q | 2026-08-06 | 0001437749-26-026271 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 1.14 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 0 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-13 | 0001437749-25-034857 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 1,121 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 614.6 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost | Share-based Payment Arrangement, Plan Modification, Incremental Cost | USD | 22,000 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-26 | 0001193125-18-096053 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | USD/shares | 133,863.84 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit | Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit | USD/shares | 0.65 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-28 | 0001193125-14-121519 |
| us-gaap | ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit | Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit | USD/shares | 7.5 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-28 | 0001193125-14-121519 |
| us-gaap | SharesIssuedPricePerShare | Shares Issued, Price Per Share | USD/shares | 0.4 | 2015-06-02 | 2015 | FY | 10-K | 2016-03-30 | 0001193125-16-523721 | |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 8.00M | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-12 | 0001193125-15-375630 | |
| us-gaap | StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants | USD | 7.06M | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-26 | 0001193125-18-096053 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 8.62M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio | Stockholders' Equity Note, Stock Split, Conversion Ratio (Deprecated 2013-01-31) | Ratio | 1.00M | 2012-04-01 | 2012-04-26 | 2012 | FY | 10-K | 2013-03-29 | 0001193125-13-133515 |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.018 | 2020-01-01 | 2020-03-31 | 2020 | Q2 | 10-Q | 2020-08-12 | 0001683168-20-002649 |
| us-gaap | StockIssued1 | Stock Issued | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-27 | 0001683168-19-000795 |
| us-gaap | StockIssuedDuringPeriodSharesAcquisitions | Stock Issued During Period, Shares, Acquisitions | shares | 1.67M | 2013-03-11 | 2013-03-12 | 2013 | FY | 10-K | 2014-03-28 | 0001193125-14-121519 |
| us-gaap | StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities | Stock Issued During Period, Shares, Conversion of Convertible Securities | shares | 0 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001193125-18-158327 |
| us-gaap | StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans | Stock Issued During Period, Shares, Employee Stock Purchase Plans | shares | 1 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-26 | 0001683168-20-000969 |
| us-gaap | StockIssuedDuringPeriodSharesIssuedForCash | Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) | shares | 100 | 2011-08-09 | 2011-09-08 | 2013 | Q2 | 10-Q | 2013-08-14 | 0001193125-13-333766 |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 3.77M | 2013-03-05 | 2013-03-06 | 2013 | FY | 10-K | 2014-03-28 | 0001193125-14-121519 |
| us-gaap | StockIssuedDuringPeriodSharesPurchaseOfAssets | Stock Issued During Period, Shares, Purchase of Assets | shares | 275,036 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-26 | 0001193125-18-096053 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | StockIssuedDuringPeriodSharesStockSplits | Stock Issued During Period, Shares, Stock Splits | shares | 66.96M | 2012-04-01 | 2012-04-26 | 2012 | FY | 10-K | 2013-03-29 | 0001193125-13-133515 |
| us-gaap | StockIssuedDuringPeriodValueAcquisitions | Stock Issued During Period, Value, Acquisitions | USD | 12.25M | 2013-01-01 | 2013-12-31 | 2014 | FY | 10-K | 2015-03-30 | 0001193125-15-110334 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 40,000 | 2025-04-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-14 | 0001683168-25-006174 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments | Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments | USD | 208,000 | 2012-01-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-13 | 0001193125-12-467372 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 1,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-22 | 0001683168-22-001833 |
| us-gaap | StockIssuedDuringPeriodValueIssuedForNoncashConsiderations | Development Stage Entities, Stock Issued, Value, Issued for Noncash Consideration (Deprecated 2015-01-31) | USD | 1 | 2011-08-09 | 2011-09-08 | 2013 | Q2 | 10-Q | 2013-08-14 | 0001193125-13-333766 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 6.49M | 2025-01-01 | 2025-03-31 | 2025 | Q2 | 10-Q | 2025-08-14 | 0001683168-25-006174 |
| us-gaap | StockIssuedDuringPeriodValueOther | Stock Issued During Period, Value, Other | USD | -58,000 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-25 | 0001683168-21-001062 |
| us-gaap | StockIssuedDuringPeriodValuePurchaseOfAssets | Stock Issued During Period, Value, Purchase of Assets | USD | 2.82M | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-27 | 0001683168-19-000795 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardGross | Stock Issued During Period, Value, Restricted Stock Award, Gross | USD | 0 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures | Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures | USD | 0 | 2023-07-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0001683168-23-007809 |
| us-gaap | StockIssuedDuringPeriodValueStockDividend | Stock Issued During Period, Value, Stock Dividend | USD | 5.95M | 2013-01-01 | 2013-06-30 | 2013 | Q2 | 10-Q | 2013-08-14 | 0001193125-13-333766 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 5,000 | 2013-01-01 | 2013-12-31 | 2014 | FY | 10-K | 2015-03-30 | 0001193125-15-110334 |
| us-gaap | TemporaryEquityAccretionToRedemptionValue | Temporary Equity, Accretion to Redemption Value | USD | -9.50M | 2012-01-01 | 2012-12-31 | 2013 | FY | 10-K | 2014-03-28 | 0001193125-14-121519 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 | |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 9.90M | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-15 | 0001193125-13-220846 | |
| us-gaap | TemporaryEquityParOrStatedValuePerShare | Temporary Equity, Par or Stated Value Per Share | USD/shares | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 10.00M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001683168-25-002134 | |
| us-gaap | ValuationAllowanceAmount | Valuation Allowance, Amount (Deprecated 2013-01-31) | USD | 2.39M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-29 | 0001193125-13-133515 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 2.61M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001437749-26-007078 |
| us-gaap | WeightedAverageNumberDilutedSharesOutstandingAdjustment | Weighted Average Number Diluted Shares Outstanding Adjustment | shares | 0 | 2014-01-01 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-14 | 0001193125-14-309149 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 4.55M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-14 | 0001683168-25-006174 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 12.83M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-22 | 0001683168-22-001833 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 11.64M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001437749-26-035280 |